Predictive and prognostic value of <sup>18</sup>F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hyehyun,Jeong

第一单位： Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

作者： Hyehyun,Jeong ^[1] ; Jeongryul,Ryu ^[2] ; Jae Ho,Jeong ^[3] ; Sangwon,Han ^[4] ; Jaewon,Hyung ^[1] ; Jin-Hee,Ahn ^[1] ; Kyung Hae,Jung ^[1] ; Sung-Bae,Kim ^[1] ; Byung-Kwan,Jeong ^[5] ; Hee Jin,Lee ^[5] ; Gyungyub,Gong ^[5] ; Dae Hyuk,Moon ^[2]

作者单位： Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. ^[1] Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea. ^[2] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. jaeho.jeong@amc.seoul.kr. ^[3] Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea. hswon87@naver.com. ^[4] Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. ^[5]

关键词 18F-FES PET Breast cancer CDK4/6 inhibitors Endocrine therapy Predictive biomarker

DOI 10.1007/s00259-024-07058-1

PMID 39806206

发布时间 2025-01-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European journal of nuclear medicine and molecular imaging

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Predictive and prognostic value of <sup>18</sup>F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.

European journal of nuclear medicine and molecular imaging

相似文献

European journal of nuclear medicine and molecular imaging

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Predictive and prognostic value of <sup>18</sup>F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.

European journal of nuclear medicine and molecular imaging

相似文献

European journal of nuclear medicine and molecular imaging

相关期刊

检索历史清除